Skip to search formSkip to main contentSkip to account menu

sirukumab

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A Novel Use of Sirukumab in Patients with Active RA
Two doses of sirukumab, compared with placebo, improves the signs and symptoms of patients with active rheumatoid arthritis… 
2017
2017
Prediction of Inhibition of Radiographic Progression By Sirukumab , an Anti – IL-6 Cytokine Monoclonal Antibody , in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic…
George Karpouzas , Tsutomu Takeuchi , Carter Thorne , Shihong Sheng , Xiaoming Li , Ravi Rao , Kaiyin Fei and Benjamin Hsu… 
2017
2017
FRI0251 SIRUKUMAB, an ANTI-IL-6 cytokine monoclonal antibody, leads to improvements in work productivity and general health status in patients with active rheumatoid arthritis refractory to ANTI-TNF…
Background Sirukumab is an anti–interleukin-6 (IL-6) monoclonal antibody that selectively binds to the cytokine with high… 
2014
2014
Drugs in Clinical Development for Rheumatoid Arthritis Summary and Table